↓ FBG (Fig. 1A); ↑ IS per week (Fig. 1B) |
(−) FBG (Fig. 1C); (−) BG in OGTT (Fig. 1, D and E); ↑ IS in OGTT (Fig. 1F) |
↑ GSIS (Fig. 3A); ↑ ATP/ADP ratio (Fig. 3B) |
↑ GSIS (Fig. 3C); ↑ ATP/ADP ratio (Fig. 3D) |
|
↑ percentage of β-cell area (Fig. 2, A and C); (−) percentage of α-cell area (Fig. 2B) |
↑ percentage of β-cell area (Fig. 2, D and F); (−) percentage of α-cell area (Fig. 2E) |
↓ pi3kca, pi3ckcd, csf2, nfκb1 in microarray analysis (Fig. 4, A–J) |
|
|
↓ p65 nuclear translocation (Fig. 5, A and B) |
|
↓ il1b RNA expression (Fig. 5C); ↓ IL-1β protein expression with inflammatory cytokine treatment (Fig. 5D) |
↓ IL-1β RNA expression (Fig. 5E); ↓ IL-1β protein expression (Fig. 5F) |
↑ GSIS with inflammatory cytokine treatment (Fig. 5G); ↓ il1b RNA expression with inflammatory cytokine treatment (Fig. 5H) |
(−) BW, FI (Fig. S2, A and B); (−) ITT (Fig. S2C); (−) OGTT (Fig. S2, D and E) |
(−) BW, FI (Fig. S3, C and D); (−) ITT (Fig. S3E) |
MPE with IKK inhibitor treatment: ↓ GSIS (Fig. 6A); ↓ ATP/ADP ratio (Fig. 6B); ↑ il1b RNA expression (Fig. 6C); ↑ IL-1β protein expression (Fig. 6D) |
|
|
↓ IL-1β expression in pancreas (Fig. S4, A and B) |
↓ IL-1β expression in pancreas (Fig. S4, C, and D) |
↓ P-p65, ↓ P-IΚB by WB (Fig. 7, A–C) |
↓ P-p65, ↓ P-IΚB by WB (Fig. 7, D–F) |
↓ P-p65, ↓ P-IΚB with inflammatory cytokine treatment by WB (Fig. 7, G–I) |
|
(−) cell proliferation in pancreas (Fig. S5); (−) apoptosis by TUNEL in pancreas (Fig. S6); (−) lipid profile, GLP-1, caspase-3, glucagon, α-glucosidase activity (Fig. S7) |
MPE with PA treatment: (−) GSIS (Fig. S8, A–E) |
|
|